A citation-based method for searching scientific literature

Rajneesh Kaur, Bettina Meiser, Tatiane Yanes, Mary-Anne Young, Kristine Barlow-Stewart, Tony Roscioli, Sian Smith, Paul A James. Fam Cancer 2019
Times Cited: 5







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High-risk women's risk perception after receiving personalized polygenic breast cancer risk information.
Laura Elenor Forrest, Sarah Dilys Sawyer, Nina Hallowell, Paul Andrew James, Mary-Anne Young. J Community Genet 2019
11
80

Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.
K D Graves, B N Peshkin, G Luta, W Tuong, M D Schwartz. Public Health Genomics 2011
44
60

Association analysis identifies 65 new breast cancer risk loci.
Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar,[...]. Nature 2017
505
60

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
309
60

Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study.
Tatiane Yanes, Bettina Meiser, Mary-Anne Young, Rajneesh Kaur, Gillian Mitchell, Kristine Barlow-Stewart, Tony Roscioli, Jane Halliday, Paul James. BMC Cancer 2017
10
60

A role for common genomic variants in the assessment of familial breast cancer.
Sarah Sawyer, Gillian Mitchell, Joanne McKinley, Georgia Chenevix-Trench, Jonathan Beesley, Xiao Qing Chen, David Bowtell, Alison H Trainer, Marion Harris, Geoffrey J Lindeman,[...]. J Clin Oncol 2012
58
60

Uptake of polygenic risk information among women at increased risk of breast cancer.
Tatiane Yanes, Bettina Meiser, Rajneesh Kaur, Maatje Scheepers-Joynt, Simone McInerny, Shelby Taylor, Kristine Barlow-Stewart, Yoland Antill, Lucinda Salmon, Courtney Smyth,[...]. Clin Genet 2020
11
60

Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.
Mary-Anne Young, Laura Elenor Forrest, Victoria-Mae Rasmussen, Paul James, Gillian Mitchell, Sarah Dilys Sawyer, Katrina Reeve, Nina Hallowell. J Genet Couns 2018
18
60

Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Tatiane Yanes, Mary-Anne Young, Bettina Meiser, Paul A James. Breast Cancer Res 2020
34
60

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
143
60

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, Andrew Lee, Penny Soucy, Joe Dennis, Susan M Domchek, Mark Robson, Amanda B Spurdle, Susan J Ramus,[...]. J Natl Cancer Inst 2017
122
40

Early adoption of BRCA1/2 testing: who and why.
Katrina Armstrong, Janet Weiner, Barbara Weber, David A Asch. Genet Med 2003
33
40

Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.
Flavia M Facio, Stephanie Brooks, Johanna Loewenstein, Susannah Green, Leslie G Biesecker, Barbara B Biesecker. Eur J Hum Genet 2011
97
40

"Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer.
Kara-Grace Leventhal, William Tuong, Beth N Peshkin, Yasmin Salehizadeh, Mary B Fishman, Susan Eggly, Kevin FitzGerald, Marc D Schwartz, Kristi D Graves. J Genet Couns 2013
26
40


Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
87
40

The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
D Gareth Evans, Adam Brentnall, Helen Byers, Elaine Harkness, Paula Stavrinos, Anthony Howell, William G Newman, Jack Cuzick. J Med Genet 2017
38
40

Understanding BRCA Mutation Carriers' Preferences for Communication of Genetic Modifiers of Breast Cancer Risk.
Shelly R Hovick, Naomi Tan, Lindsey Morr, Leigha Senter, Daniel D Kinnamon, Robert E Pyatt, Amanda E Toland. J Health Commun 2019
5
40

Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families.
Inge M M Lakeman, Florentine S Hilbers, Mar Rodríguez-Girondo, Andrew Lee, Maaike P G Vreeswijk, Antoinette Hollestelle, Caroline Seynaeve, Hanne Meijers-Heijboer, Jan C Oosterwijk, Nicoline Hoogerbrugge,[...]. J Med Genet 2019
15
40

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
267
40

Women's responses and understanding of polygenic breast cancer risk information.
T Yanes, R Kaur, B Meiser, M Scheepers-Joynt, S McInerny, K Barlow-Stewart, Y Antill, L Salmon, C Smyth, P A James,[...]. Fam Cancer 2020
6
40


Interest in genomic SNP testing for prostate cancer risk: a pilot survey.
Michael J Hall, Karen J Ruth, David Yt Chen, Laura M Gross, Veda N Giri. Hered Cancer Clin Pract 2015
5
20

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
D Gareth R Evans, Elaine F Harkness, Adam R Brentnall, Elke M van Veen, Susan M Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J Howell,[...]. Breast Cancer Res Treat 2019
24
20

Development of a knowledge scale about breast cancer and heredity (BCHK).
N Ondrusek, E Warner, V Goel. Breast Cancer Res Treat 1999
20
20

Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire.
Joel Erblich, Karen Brown, Youngmee Kim, Heiddis B Valdimarsdottir, Barbara E Livingston, Dana H Bovbjerg. Patient Educ Couns 2005
50
20

Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk.
A E Anderson, K G Flores, W Boonyasiriwat, A Gammon, W Kohlmann, W C Birmingham, M D Schwartz, J Samadder, K Boucher, A Y Kinney. Public Health Genomics 2014
16
20

Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
114
20


Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types.
Claire E Wakefield, Nadine A Kasparian, Bettina Meiser, Judi Homewood, Judy Kirk, Kathy Tucker. Genet Test 2007
7
20

Predictors of genetic testing decisions: a systematic review and critique of the literature.
Kate Sweeny, Arezou Ghane, Angela M Legg, Ho Phi Huynh, Sara E Andrews. J Genet Couns 2014
35
20

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
20

Relaxing the rule of ten events per variable in logistic and Cox regression.
Eric Vittinghoff, Charles E McCulloch. Am J Epidemiol 2007
20


Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
Kristi Läll, Maarja Lepamets, Marili Palover, Tõnu Esko, Andres Metspalu, Neeme Tõnisson, Peeter Padrik, Reedik Mägi, Krista Fischer. BMC Cancer 2019
17
20

Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
Lisa Jeffers, Patrick J Morrison, Eilis McCaughan, Donna Fitzsimons. Eur J Oncol Nurs 2014
11
20

A simulation study of the number of events per variable in logistic regression analysis.
P Peduzzi, J Concato, E Kemper, T R Holford, A R Feinstein. J Clin Epidemiol 1996
20

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.
Taru A Muranen, Dario Greco, Carl Blomqvist, Kristiina Aittomäki, Sofia Khan, Frans Hogervorst, Senno Verhoef, Paul D P Pharoah, Alison M Dunning, Mitul Shah,[...]. Genet Med 2017
44
20

Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors.
Amelie G Ramirez, Fabiola E Aparicio-Ting, Sandra San Miguel de Majors, Alexander R Miller. Ethn Dis 2006
34
20

Need for certainty and interest in genetic testing.
R T Croyle, D S Dutson, V T Tran, Y C Sun. Womens Health 1995
21
20

Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.
Nadine A Kasparian, Bettina Meiser, Phyllis N Butow, Judy M Simpson, Graham J Mann. Genet Med 2009
68
20

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.
C Foster, D G R Evans, R Eeles, D Eccles, S Ashley, L Brooks, T Cole, J Cook, R Davidson, H Gregory,[...]. Genet Test 2004
48
20

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.
Amit V Khera, Mark Chaffin, Krishna G Aragam, Mary E Haas, Carolina Roselli, Seung Hoan Choi, Pradeep Natarajan, Eric S Lander, Steven A Lubitz, Patrick T Ellinor,[...]. Nat Genet 2018
838
20

What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer.
S C Sanderson, S C O'Neill, L A Bastian, G Bepler, C M McBride. Public Health Genomics 2010
61
20

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Roger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon, Penny Soucy, Joe Dennis,[...]. Nat Genet 2017
144
20


Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation.
Rebecca Howe, Talya Miron-Shatz, Yaniv Hanoch, Zehra B Omer, Cristina O'Donoghue, Elissa M Ozanne. J Genet Couns 2015
13
20

Consumers' use of web-based information and their decisions about multiplex genetic susceptibility testing.
Kimberly A Kaphingst, Colleen M McBride, Christopher Wade, Sharon Hensley Alford, Lawrence C Brody, Andreas D Baxevanis. J Med Internet Res 2010
47
20

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
Mia M Gaudet, Karoline B Kuchenbaecker, Joseph Vijai, Robert J Klein, Tomas Kirchhoff, Lesley McGuffog, Daniel Barrowdale, Alison M Dunning, Andrew Lee, Joe Dennis,[...]. PLoS Genet 2013
85
20

Improving communication of breast cancer recurrence risk.
Noel T Brewer, Alice R Richman, Jessica T DeFrank, Valerie F Reyna, Lisa A Carey. Breast Cancer Res Treat 2012
43
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.